12:40:53 EDT Mon 06 May 2024
Enter Symbol
or Name
USA
CA



News for U:JSPR from 2023-05-07 to 2024-05-06 - 13 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2024-04-02 16:30U:JSPRNews ReleaseJasper Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
2024-03-21 16:30U:JSPRNews ReleaseJasper Therapeutics to Participate in the H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference
2024-03-19 08:00U:JSPRNews ReleaseJasper Therapeutics Announces First Patient Dosed in Phase 1b/2a SPOTLIGHT Clinical Study of Briquilimab in Chronic Inducible Urticaria
2024-03-15 08:00U:JSPRNews ReleaseNew Positive Data Presented on Briquilimab Conditioning in Patients with Fanconi Anemia
2024-03-04 07:31U:JSPRNews ReleaseJasper Therapeutics Reports Fiscal 2023 Financial Results and Recent Corporate Developments
2024-02-26 16:31U:JSPRNews ReleaseJasper Therapeutics to Present at the 43rd Annual TD Cowen Healthcare Conference
2024-02-23 08:01U:JSPRNews ReleaseJasper Therapeutics Presents Data from Preclinical Briquilimab Studies at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
2024-02-07 08:01U:JSPRNews ReleaseJasper Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Conference
2024-02-06 09:00U:JSPRNews ReleaseJasper Therapeutics Announces Pricing of $50 Million Underwritten Offering of Common Stock
2024-02-05 08:00U:JSPRNews ReleaseJasper Therapeutics Announces Preclinical Data Presentations at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
2024-02-02 08:01U:JSPRNews ReleaseJasper Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2024-01-05 08:31U:JSPRNews ReleaseJasper Therapeutics Highlights Recent Accomplishments and Key Upcoming Milestones
2024-01-02 08:00U:JSPRNews ReleaseJasper Therapeutics, Inc. Announces Reverse Stock Split